Stakeholders’ Consultation on EudraLex Volume 4 – Good Manufacturing Practice Guidelines: Chapter 4, Annex 11 and New Annex 22

01/09/2025

The organisations representing stakeholders involved in GMP activities are encouraged to take part in the consultation and to receive all the comments of this consultation from their members, to compile and send the comments via the EU Survey tool.

Read the consultation published by Directorate-General for Health and Food Safety on 7 July 2025.

lsgilbert

Voir tous les articles

---

OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (1 septembre 2025). Stakeholders’ Consultation on EudraLex Volume 4 – Good Manufacturing Practice Guidelines: Chapter 4, Annex 11 and New Annex 22. ELSIBI. Consulté le 11 octobre 2026 à l’adresse https://doi.org/10.58079/14k1b

---

Étiquettes : European CommissionGood Manufacturing PracticeGuidelinesMedicines

• Article suivant Adoption of Commission Delegated Regulation (EU) 2025/788 amending Delegated Regulation (EU) 2023/2197 as regards the date of application
• Article précédent Video recordings – EU health technology assessment: Advent of a new era of collaboration – 2 July 2025

Vous aimerez aussi...

• 0

  EURORDIS-Rare Diseases Europe publishes a Joint Statement with EFPIA on proposals to improve patient access to medicines

  20/07/2022

   par egennet

   par egennet · Published 20/07/2022

• 0

  Solve-RD partners call for strengthening of rare disease diagnosis in Europe

  05/10/2023

   par bartosb

   par bartosb · Published 05/10/2023

• 0

  EDQM releases new edition of the Tissue and Cells Guide, providing state-of-the-art guidance for healthcare professionals (Cell and Gene Therapy Catapult – Regulatory Round-up – December 2022)

  17/05/2023

   par adelage

   par adelage · Published 17/05/2023 · Last modified 08/06/2023